← Open Payments lookup

MICHAELINE BAILEY: Open Payments

NPI 1447890298 · SOUTHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,621 in 83 payments from 16 companies in 2025. Trend: 2023 $634 · 2024 $1,871 · 2025 $1,621

Food & beverage: $1,621
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP22$454
ABBVIE INC.16$254
Novo Nordisk Inc9$167
Corcept Therapeutics6$146
Lilly USA, LLC5$76
GlaxoSmithKline, LLC.4$76
Boehringer Ingelheim Pharmaceuticals, Inc.4$69
Otsuka America Pharmaceutical, Inc.2$65
Sumitomo Pharma America, Inc.3$63
REVANCE THERAPEUTICS, INC.2$62

Products named: FARXIGA, LINZESS, Korlym, AIRSUPRA, Ozempic, JARDIANCE, TRELEGY ELLIPTA, REXULTI.

Industry payments across MS — which companies pay providers there.